MedPath

SERZONE-5HT2

SERZONE-5HT2

Discontinued
DIN Number

02087383

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

bristol-myers squibb canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02087383
AIG Number0125963005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AX06 NEFAZODONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.04.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

NEFAZODONE HYDROCHLORIDEActive
Strength: 150 MG
Monograph: NEFAZODONE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.